Evidence map›Paper›PMID 40574802›Full record

ArticleFrontiers in genetics2025

Highly multiplexed molecular inversion probe panel in

Karamoko Niaré, Rebecca Crudale, Abebe A Fola, Neeva Wernsman Young, Victor Asua, Melissa D Conrad, Pierre Gashema, Anita Ghansah, Stan Hangi, Deus S Ishengoma and 6 more

Abstract read
In one paragraph

Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Malaria control and the unexpected spread of diagnostic-resistantbioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Artemisinin resistantmedRxiv : the preprint server for health sciences · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Karamoko NiaréDepartment of Pathology and Laboratory Medicine, Brown University, Providence, RI, United States.
Rebecca CrudaleDepartment of Pathology and Laboratory Medicine, Brown University, Providence, RI, United States.
Abebe A FolaDepartment of Pathology and Laboratory Medicine, Brown University, Providence, RI, United States.
Neeva Wernsman YoungCenter for Computational Molecular Biology, Brown University, Providence, RI, United States.
Victor AsuaInfectious Diseases Research Collaboration, Kampala, Uganda.
Melissa D ConradDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Pierre GashemaCenter for Genomic Biology, Institut d'Enseignement Supérieur de Ruhengeri, Ruhengeri, Rwanda.
Anita GhansahNoguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.
Stan HangiDepartment of Pediatrics, HEAL Africa, Goma, Democratic Republic of Congo.
Deus S IshengomaNational Institute for Medical Research, Dar es Salaam, Tanzania.
Jean-Baptiste MazaratiCenter for Genomic Biology, Institut d'Enseignement Supérieur de Ruhengeri, Ruhengeri, Rwanda.
Ayalew Jejaw ZelekeDepartment of Medical Parasitology, School of Biomedical and Laboratory Science, University of Gondar, Gondar, Ethiopia.
Philip J RosenthalDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Abdoulaye A DjimdéPathogens genomics Diversity Network Africa, Bamako, Mali.
Jonathan J JulianoInstitute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC, United States.
Jeffrey A BaileyDepartment of Pathology and Laboratory Medicine, Brown University, Providence, RI, United States.

Funding

Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipelineR01AI139179 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Philip Jon Rosenthal · 2018 to 2026
$6.3M
Tracking the flow of malaria parasites and drug resistance within the DRC and across its bordersR01AI139520 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BAILEY, JEFFREY A. · 2018 to 2023
$3.6M
Impacts of Environment, Host Genetics and Antigen Diversity on Malaria Vaccine EfficacyR01AI137410 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BAILEY, JEFFREY A., EMCH, MICHAEL · 2018 to 2023
$3.6M
Surveillance to track and characterize antimalarial resistance trends in Ugandan Plasmodium falciparum parasites (STARTUP)R01AI173557 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Melissa D Conrad · 2023 to 2026
$2.9M
NIAID NIH HHS R01 AI137410NIAID NIH HHS R01 AI139179NIAID NIH HHS R01 AI139520NIAID NIH HHS R01 AI173557
6 · The paper itself

Abstract

Introduction: The use of next-generation sequencing technologies (NGS) to study parasite populations and their response and evolution to interventions is important to support malaria control and elimination efforts. While whole-genome sequencing (WGS) is optimal in terms of assessing the entire genome, it is costly for numerous samples. Targeted approaches selectively enriching for the sequence of interest are more affordable and have higher throughput but sometimes lack adequate information content for key analyses. Methods: We have developed a highly multiplexed molecular inversion probe (MIP) panel (IBC2FULL) targeting 4,264 single-nucleotide polymorphisms (SNPs) with ≥5% minor allele frequency (MAF) in Sub-Saharan African regions from publicly available Results: The new panel IBC2FULL consisted of 2,128 MIPs (containing 4,264 common SNPs) spaced by 5.1-18.4 kb across the entire genome. While these microhaplotypes were developed based on variations from Sub-Saharan African WGS data, 59.3% (2,529) of SNPs were also common in Southeast Asia. The MIPs were balanced to produce more a uniform and higher depth of coverage at low parasitemia (100 parasites/μL) along with MIPs targeting antimalarial drug resistance genes. Comparing targeted regions extracted from public WGS, we observed that IBC2FULL provided a higher resolution of the local population structure in Sub-Saharan Africa than current PCR-based targeted sequencing panels. For sequencing field samples (n = 140), IBC2FULL approximated WGS measures of relatedness, population structure, and COI. Interestingly, genome-wide analysis of extended haplotype homozygosity detected the same major peaks of selection as WGS. We also chose a subset of 305 high-performing MIPs to create a core panel (IBC2CORE) that produced high-quality data for basic population genomic analysis and accurate estimation of COI. Discussion: IBC2FULL and IBC2CORE panels have been designed to provide an improved platform for malaria genomic epidemiology and biology that can approximate WGS for many applications and is deployable for malaria molecular surveillance in resource-limited settings.

Indexed as

genomic epidemiologymalariamolecular inversion probemolecular surveillancePlasmodium falciparumtargeted sequencing

Identifiers

PMID40574802
PMCPMC12198981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.